Biotech developing RNA therapies for aging-related diseases such as cancer and neurodegeneration.
| Date | Round | Amount |
|---|---|---|
| Aug 2023 | Seed Brazil/California biotech Aptah Bio opened a US$8M round (with venture builder Vesper Ventures committing about 10%) to finish animal studies and start human trials. | $8M |